These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 30481403)

  • 21. Green tea extract treatment reduces NFκB activation in mice with diet-induced nonalcoholic steatohepatitis by lowering TNFR1 and TLR4 expression and ligand availability.
    Li J; Sapper TN; Mah E; Moller MV; Kim JB; Chitchumroonchokchai C; McDonald JD; Bruno RS
    J Nutr Biochem; 2017 Mar; 41():34-41. PubMed ID: 28038359
    [TBL] [Abstract][Full Text] [Related]  

  • 22. INT-767 improves histopathological features in a diet-induced
    Roth JD; Feigh M; Veidal SS; Fensholdt LK; Rigbolt KT; Hansen HH; Chen LC; Petitjean M; Friley W; Vrang N; Jelsing J; Young M
    World J Gastroenterol; 2018 Jan; 24(2):195-210. PubMed ID: 29375205
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of Yi Guan Jian decoction on differentiation of bone marrow mesenchymalstem cells into hepatocyte-like cells in dimethylnitrosamine-induced liver cirrhosis in mice.
    Xiang Y; Pang BY; Zhang Y; Xie QL; Zhu Y; Leng AJ; Lu LQ; Chen HL
    Mol Med Rep; 2017 Feb; 15(2):613-626. PubMed ID: 28035356
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Involvement of G protein-coupled receptor kinase 2 (GRK2) in the development of non-alcoholic steatosis and steatohepatitis in mice and humans.
    Cruces-Sande M; Vila-Bedmar R; Arcones AC; González-Rodríguez Á; Rada P; Gutiérrez-de-Juan V; Vargas-Castrillón J; Iruzubieta P; Sánchez-González C; Formentini L; Crespo J; García-Monzón C; Martínez-Chantar ML; Valverde ÁM; Mayor F; Murga C
    Biochim Biophys Acta Mol Basis Dis; 2018 Dec; 1864(12):3655-3667. PubMed ID: 30261289
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Myeloperoxidase-Hepatocyte-Stellate Cell Cross Talk Promotes Hepatocyte Injury and Fibrosis in Experimental Nonalcoholic Steatohepatitis.
    Pulli B; Ali M; Iwamoto Y; Zeller MW; Schob S; Linnoila JJ; Chen JW
    Antioxid Redox Signal; 2015 Dec; 23(16):1255-69. PubMed ID: 26058518
    [TBL] [Abstract][Full Text] [Related]  

  • 26. LPS-induced TNF-α factor mediates pro-inflammatory and pro-fibrogenic pattern in non-alcoholic fatty liver disease.
    Ceccarelli S; Panera N; Mina M; Gnani D; De Stefanis C; Crudele A; Rychlicki C; Petrini S; Bruscalupi G; Agostinelli L; Stronati L; Cucchiara S; Musso G; Furlanello C; Svegliati-Baroni G; Nobili V; Alisi A
    Oncotarget; 2015 Dec; 6(39):41434-52. PubMed ID: 26573228
    [TBL] [Abstract][Full Text] [Related]  

  • 27. SIRT1 upregulation protects against liver injury induced by a HFD through inhibiting CD36 and the NF‑κB pathway in mouse kupffer cells.
    Niu B; He K; Li P; Gong J; Zhu X; Ye S; Ou Z; Ren G
    Mol Med Rep; 2018 Aug; 18(2):1609-1615. PubMed ID: 29845302
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CD44 is a key player in non-alcoholic steatohepatitis.
    Patouraux S; Rousseau D; Bonnafous S; Lebeaupin C; Luci C; Canivet CM; Schneck AS; Bertola A; Saint-Paul MC; Iannelli A; Gugenheim J; Anty R; Tran A; Bailly-Maitre B; Gual P
    J Hepatol; 2017 Aug; 67(2):328-338. PubMed ID: 28323124
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Necroptosis is a key pathogenic event in human and experimental murine models of non-alcoholic steatohepatitis.
    Afonso MB; Rodrigues PM; Carvalho T; Caridade M; Borralho P; Cortez-Pinto H; Castro RE; Rodrigues CM
    Clin Sci (Lond); 2015 Oct; 129(8):721-39. PubMed ID: 26201023
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Strain dependence of diet-induced NASH and liver fibrosis in obese mice is linked to diabetes and inflammatory phenotype.
    Farrell GC; Mridha AR; Yeh MM; Arsov T; Van Rooyen DM; Brooling J; Nguyen T; Heydet D; Delghingaro-Augusto V; Nolan CJ; Shackel NA; McLennan SV; Teoh NC; Larter CZ
    Liver Int; 2014 Aug; 34(7):1084-93. PubMed ID: 24107103
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Nicotine alleviates the liver inflammation of non-alcoholic steatohepatitis induced by high-fat and high-fructose in mice].
    Chen XM; Li FQ; Yan S; Wu XC; Tang CL
    Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Oct; 48(5):777-782. PubMed ID: 27752155
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mainstream cigarette smoke accelerates the progression of nonalcoholic steatohepatitis by modulating Kupffer cell-mediated hepatocellular apoptosis in adolescent mice.
    Park S; Kim JW; Yun H; Choi SJ; Lee SH; Choi KC; Lim CW; Lee K; Kim B
    Toxicol Lett; 2016 Aug; 256():53-63. PubMed ID: 27180087
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-chain fatty acid activates hepatocytes through CD36 mediated oxidative stress.
    Liu J; Yang P; Zuo G; He S; Tan W; Zhang X; Su C; Zhao L; Wei L; Chen Y; Ruan X; Chen Y
    Lipids Health Dis; 2018 Jul; 17(1):153. PubMed ID: 30016988
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A novel role of astrocyte elevated gene-1 (AEG-1) in regulating nonalcoholic steatohepatitis (NASH).
    Srivastava J; Robertson CL; Ebeid K; Dozmorov M; Rajasekaran D; Mendoza R; Siddiq A; Akiel MA; Jariwala N; Shen XN; Windle JJ; Subler MA; Mukhopadhyay ND; Giashuddin S; Ghosh S; Lai Z; Chen Y; Fisher PB; Salem AK; Sanyal AJ; Sarkar D
    Hepatology; 2017 Aug; 66(2):466-480. PubMed ID: 28437865
    [TBL] [Abstract][Full Text] [Related]  

  • 35. p53/p66Shc-mediated signaling contributes to the progression of non-alcoholic steatohepatitis in humans and mice.
    Tomita K; Teratani T; Suzuki T; Oshikawa T; Yokoyama H; Shimamura K; Nishiyama K; Mataki N; Irie R; Minamino T; Okada Y; Kurihara C; Ebinuma H; Saito H; Shimizu I; Yoshida Y; Hokari R; Sugiyama K; Hatsuse K; Yamamoto J; Kanai T; Miura S; Hibi T
    J Hepatol; 2012 Oct; 57(4):837-43. PubMed ID: 22641095
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of curcumin supplementation on serum expression of select cytokines and chemokines in a female rat model of nonalcoholic steatohepatitis.
    Pickich MB; Hargrove MW; Phillips CN; Healy JC; Moore AN; Roberts MD; Martin JS
    BMC Res Notes; 2019 Aug; 12(1):496. PubMed ID: 31399137
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ezetimibe, an NPC1L1 inhibitor, is a potent Nrf2 activator that protects mice from diet-induced nonalcoholic steatohepatitis.
    Lee DH; Han DH; Nam KT; Park JS; Kim SH; Lee M; Kim G; Min BS; Cha BS; Lee YS; Sung SH; Jeong H; Ji HW; Lee MJ; Lee JS; Lee HY; Chun Y; Kim J; Komatsu M; Lee YH; Bae SH
    Free Radic Biol Med; 2016 Oct; 99():520-532. PubMed ID: 27634173
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Glycine protects against high sucrose and high fat-induced non-alcoholic steatohepatitis in rats.
    Zhou X; Han D; Xu R; Wu H; Qu C; Wang F; Wang X; Zhao Y
    Oncotarget; 2016 Dec; 7(49):80223-80237. PubMed ID: 27784003
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chronic administration of recombinant IL-6 upregulates lipogenic enzyme expression and aggravates high-fat-diet-induced steatosis in IL-6-deficient mice.
    Vida M; Gavito AL; Pavón FJ; Bautista D; Serrano A; Suarez J; Arrabal S; Decara J; Romero-Cuevas M; Rodríguez de Fonseca F; Baixeras E
    Dis Model Mech; 2015 Jul; 8(7):721-31. PubMed ID: 26035386
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Wheat-bran autolytic peptides containing a branched-chain amino acid attenuate non-alcoholic steatohepatitis via the suppression of oxidative stress and the upregulation of AMPK/ACC in high-fat diet-fed mice.
    Kawaguchi T; Ueno T; Nogata Y; Hayakawa M; Koga H; Torimura T
    Int J Mol Med; 2017 Feb; 39(2):407-414. PubMed ID: 28000843
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.